Literature DB >> 19172061

SHV-28, an extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae in south India.

S A Jemima1, S Verghese.   

Abstract

SHV-28, an extended spectrum beta-lactamase from a clinical isolate of Klebsiella pneumoniae , had an isoelectric point of 7.6 and a substrate profile showing preferential hydrolysis for cefotaxime over ceftazidime. It differed from SHV-1 by one amino acid substitution. The conserved S-T-F-K and K-T-G motifs were identified by SHV-28 protein sequencing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172061

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  3 in total

1.  Total alkaloids from Sophora alopecuroides L. increase susceptibility of extended-spectrum β-lactamases producing Escherichia coli isolates to cefotaxime and ceftazidime.

Authors:  Xue-zhang Zhou; Fang Jia; Xiao-ming Liu; Cong Yang; Li Zhao; Yu-jiong Wang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

2.  Characterization of Carbapenem-Resistant Klebsiella pneumoniae ST15 Clone Coproducing KPC-2, CTX-M-15 and SHV-28 Spread in an Intensive Care Unit of a Tertiary Hospital.

Authors:  Yaping Han; Lei Huang; Chengcheng Liu; Xu Huang; Ruiying Zheng; Yanfei Lu; Wenying Xia; Fang Ni; Yaning Mei; Genyan Liu
Journal:  Infect Drug Resist       Date:  2021-03-03       Impact factor: 4.003

3.  Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in klebsiella spp. from companion animals in Italy.

Authors:  Valentina Donati; Fabiola Feltrin; Rene S Hendriksen; Christina Aaby Svendsen; Gessica Cordaro; Aurora García-Fernández; Serena Lorenzetti; Raniero Lorenzetti; Antonio Battisti; Alessia Franco
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.